FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2322841664> ?p ?o ?g. }

• W2322841664 endingPage "229" @default.
• W2322841664 startingPage "222" @default.
• W2322841664 abstract "Wilms tumor gene (WT1) is a reliable marker for minimal residual disease assessment in acute leukemia children. This study was designed to demonstrate the potential use of WT1 to establish quality of remission in acute leukemia children for early identification of children at high risk of relapse. This study based on a quantitative Real–Time polymerase chain reaction (PCR) (TaqMan) assay in bone marrow samples collected from 45 acute myeloid leukemia children at diagnosis and during follow-up was established. Our results revealed, there was no significant association between WT1expression,at diagnosis, and either of gender, organomegally, total leucocytic count (TLC), French-AmericanBritish system (FAB) subtypes, CD34 expression, cytogenetic studies, percentage of blast infiltration or response to induction therapy. By comparing the results obtained at day 14 and those obtained at day 28, we cannot depend on WT1gene expression or MRD detection at day14 in predicting resistance to treatment or predicting mortality (p= 0.12). In contrast WT1 gene expression or MRD detection values after induction therapy (at day28) is an independent prognostic risk factor of relapse (p= 0.001) and death (p= 0.001). The blast percentage was significantly correlated to the WT1expression levels at day 28.The presence of MRD or WT1gene expression at the end of induction therapy is an extremely powerful adverse prognostic factor.WT1 at presentation has no prognostic significance whereas a high WT1 expression after induction therapy is a predictor for poor outcome. A rise inWT1expression during treatment is a predictor for relapse. WT1 expression is a valuable and important tool for MRD study in AML and the presence of MRD value at the end of induction therapy is an extremely powerful adverse prognostic factor despite of achievement of morphological remission." @default.
• W2322841664 created "2016-06-24" @default.
• W2322841664 creator A5029508292 @default.
• W2322841664 date "2015-12-01" @default.
• W2322841664 modified "2023-10-14" @default.
• W2322841664 title "New Insight Towards Prognosis in Pediatric Acute Myeloid Leukemia: Comparative Study." @default.
• W2322841664 cites W1964661337 @default.
• W2322841664 cites W1992829933 @default.
• W2322841664 cites W1994328316 @default.
• W2322841664 cites W2021380995 @default.
• W2322841664 cites W2036436627 @default.
• W2322841664 cites W2036862498 @default.
• W2322841664 cites W2070153319 @default.
• W2322841664 cites W2074269699 @default.
• W2322841664 cites W2078153175 @default.
• W2322841664 cites W2082229999 @default.
• W2322841664 cites W2089596135 @default.
• W2322841664 cites W2097984158 @default.
• W2322841664 cites W2106194243 @default.
• W2322841664 cites W2113027268 @default.
• W2322841664 cites W2115255609 @default.
• W2322841664 cites W2118250079 @default.
• W2322841664 cites W2119292205 @default.
• W2322841664 cites W2125925299 @default.
• W2322841664 cites W2127712120 @default.
• W2322841664 cites W2159763992 @default.
• W2322841664 cites W2255917396 @default.
• W2322841664 cites W227961483 @default.
• W2322841664 cites W2401583947 @default.
• W2322841664 cites W2464657412 @default.
• W2322841664 doi "https://doi.org/10.4999/uhod.1071" @default.
• W2322841664 hasPublicationYear "2015" @default.
• W2322841664 type Work @default.
• W2322841664 sameAs 2322841664 @default.
• W2322841664 citedByCount "0" @default.
• W2322841664 crossrefType "journal-article" @default.
• W2322841664 hasAuthorship W2322841664A5029508292 @default.
• W2322841664 hasBestOaLocation W23228416641 @default.
• W2322841664 hasConcept C126322002 @default.
• W2322841664 hasConcept C143998085 @default.
• W2322841664 hasConcept C177713679 @default.
• W2322841664 hasConcept C187212893 @default.
• W2322841664 hasConcept C2778729363 @default.
• W2322841664 hasConcept C2779282312 @default.
• W2322841664 hasConcept C71924100 @default.
• W2322841664 hasConceptScore W2322841664C126322002 @default.
• W2322841664 hasConceptScore W2322841664C143998085 @default.
• W2322841664 hasConceptScore W2322841664C177713679 @default.
• W2322841664 hasConceptScore W2322841664C187212893 @default.
• W2322841664 hasConceptScore W2322841664C2778729363 @default.
• W2322841664 hasConceptScore W2322841664C2779282312 @default.
• W2322841664 hasConceptScore W2322841664C71924100 @default.
• W2322841664 hasIssue "4" @default.
• W2322841664 hasLocation W23228416641 @default.
• W2322841664 hasOpenAccess W2322841664 @default.
• W2322841664 hasPrimaryLocation W23228416641 @default.
• W2322841664 hasRelatedWork W134642214 @default.
• W2322841664 hasRelatedWork W2012639655 @default.
• W2322841664 hasRelatedWork W2048952699 @default.
• W2322841664 hasRelatedWork W2065164347 @default.
• W2322841664 hasRelatedWork W2410491650 @default.
• W2322841664 hasRelatedWork W2604682584 @default.
• W2322841664 hasRelatedWork W4224021869 @default.
• W2322841664 hasRelatedWork W4252371801 @default.
• W2322841664 hasRelatedWork W4362547255 @default.
• W2322841664 hasRelatedWork W4362550358 @default.
• W2322841664 hasVolume "25" @default.
• W2322841664 isParatext "false" @default.
• W2322841664 isRetracted "false" @default.
• W2322841664 magId "2322841664" @default.
• W2322841664 workType "article" @default.